Liver transplantation

Andres F. Carrion, Kalyan R Bhamidimarri

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Liver transplantation is the only therapeutic option offering definitive treatment for end-stage liver disease, acute liver failure, and several other diseases including hepatocellular carcinoma. Improved outcomes reflect advances in the selection of potential candidates, surgical technique, postoperative care, and immunosuppression. Live-donor liver transplantation (LDLT) offers some important advantages over deceased-donor liver transplantation, but its widespread applicability has been hampered by a high risk of complications in the donor and recipient and even donor mortality; therefore LDLT currently represents only a small fraction of the total number of liver transplants performed yearly. Long-term care of liver transplant recipients is critical to the success of liver transplantation and should focus on timely recognition of complications, management of immunosuppression, treatment of comorbid conditions, and preventive health.

Original languageEnglish (US)
Title of host publicationHandbook of Liver Disease
PublisherElsevier
Pages452-469
Number of pages18
ISBN (Electronic)9780323478823
ISBN (Print)9780323478748
DOIs
StatePublished - Aug 24 2017

Fingerprint

Liver Transplantation
Tissue Donors
Immunosuppression
End Stage Liver Disease
Acute Liver Failure
Postoperative Care
Liver
Long-Term Care
Hepatocellular Carcinoma
Therapeutics
Transplants
Mortality
Health

Keywords

  • Complications
  • Contraindications
  • Immunosuppression
  • Indications
  • Liver transplantation
  • Model for End-stage Liver Disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Carrion, A. F., & Bhamidimarri, K. R. (2017). Liver transplantation. In Handbook of Liver Disease (pp. 452-469). Elsevier. https://doi.org/10.1016/B978-0-323-47874-8.00033-X

Liver transplantation. / Carrion, Andres F.; Bhamidimarri, Kalyan R.

Handbook of Liver Disease. Elsevier, 2017. p. 452-469.

Research output: Chapter in Book/Report/Conference proceedingChapter

Carrion, AF & Bhamidimarri, KR 2017, Liver transplantation. in Handbook of Liver Disease. Elsevier, pp. 452-469. https://doi.org/10.1016/B978-0-323-47874-8.00033-X
Carrion AF, Bhamidimarri KR. Liver transplantation. In Handbook of Liver Disease. Elsevier. 2017. p. 452-469 https://doi.org/10.1016/B978-0-323-47874-8.00033-X
Carrion, Andres F. ; Bhamidimarri, Kalyan R. / Liver transplantation. Handbook of Liver Disease. Elsevier, 2017. pp. 452-469
@inbook{b4ed3d02b00540e69a9e130a3af80945,
title = "Liver transplantation",
abstract = "Liver transplantation is the only therapeutic option offering definitive treatment for end-stage liver disease, acute liver failure, and several other diseases including hepatocellular carcinoma. Improved outcomes reflect advances in the selection of potential candidates, surgical technique, postoperative care, and immunosuppression. Live-donor liver transplantation (LDLT) offers some important advantages over deceased-donor liver transplantation, but its widespread applicability has been hampered by a high risk of complications in the donor and recipient and even donor mortality; therefore LDLT currently represents only a small fraction of the total number of liver transplants performed yearly. Long-term care of liver transplant recipients is critical to the success of liver transplantation and should focus on timely recognition of complications, management of immunosuppression, treatment of comorbid conditions, and preventive health.",
keywords = "Complications, Contraindications, Immunosuppression, Indications, Liver transplantation, Model for End-stage Liver Disease",
author = "Carrion, {Andres F.} and Bhamidimarri, {Kalyan R}",
year = "2017",
month = "8",
day = "24",
doi = "10.1016/B978-0-323-47874-8.00033-X",
language = "English (US)",
isbn = "9780323478748",
pages = "452--469",
booktitle = "Handbook of Liver Disease",
publisher = "Elsevier",
address = "Netherlands",

}

TY - CHAP

T1 - Liver transplantation

AU - Carrion, Andres F.

AU - Bhamidimarri, Kalyan R

PY - 2017/8/24

Y1 - 2017/8/24

N2 - Liver transplantation is the only therapeutic option offering definitive treatment for end-stage liver disease, acute liver failure, and several other diseases including hepatocellular carcinoma. Improved outcomes reflect advances in the selection of potential candidates, surgical technique, postoperative care, and immunosuppression. Live-donor liver transplantation (LDLT) offers some important advantages over deceased-donor liver transplantation, but its widespread applicability has been hampered by a high risk of complications in the donor and recipient and even donor mortality; therefore LDLT currently represents only a small fraction of the total number of liver transplants performed yearly. Long-term care of liver transplant recipients is critical to the success of liver transplantation and should focus on timely recognition of complications, management of immunosuppression, treatment of comorbid conditions, and preventive health.

AB - Liver transplantation is the only therapeutic option offering definitive treatment for end-stage liver disease, acute liver failure, and several other diseases including hepatocellular carcinoma. Improved outcomes reflect advances in the selection of potential candidates, surgical technique, postoperative care, and immunosuppression. Live-donor liver transplantation (LDLT) offers some important advantages over deceased-donor liver transplantation, but its widespread applicability has been hampered by a high risk of complications in the donor and recipient and even donor mortality; therefore LDLT currently represents only a small fraction of the total number of liver transplants performed yearly. Long-term care of liver transplant recipients is critical to the success of liver transplantation and should focus on timely recognition of complications, management of immunosuppression, treatment of comorbid conditions, and preventive health.

KW - Complications

KW - Contraindications

KW - Immunosuppression

KW - Indications

KW - Liver transplantation

KW - Model for End-stage Liver Disease

UR - http://www.scopus.com/inward/record.url?scp=85054265537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054265537&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-47874-8.00033-X

DO - 10.1016/B978-0-323-47874-8.00033-X

M3 - Chapter

AN - SCOPUS:85054265537

SN - 9780323478748

SP - 452

EP - 469

BT - Handbook of Liver Disease

PB - Elsevier

ER -